Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2022-01-27 11:00 am Unchanged | 13G | LIGAND PHARMACEUTICALS INC LGND | BlackRock Inc. BLK | 2,742,808 16.4% | 0 (Unchanged) | View |
2022-01-25 3:03 pm Purchase | 13G | LIGAND PHARMACEUTICALS INC LGND | BlackRock Inc. BLK | 2,742,808 16.4% | 776,812 (+39.51%) | View |
2021-10-12 09:29 am Purchase | 13G | LIGAND PHARMACEUTICALS INC LGND | VANGUARD GROUP INC | 1,722,291 10.33% | 263,366 (+18.05%) | View |
2021-05-07 3:55 pm Sale | 13G | LIGAND PHARMACEUTICALS INC LGND | WILLIAM BLAIR INVESTMENT MANAGEMENT LLC | 1,279,548 7.7% | -761,497 (-37.31%) | View |
2021-02-16 5:30 pm Purchase | 13G | LIGAND PHARMACEUTICALS INC LGND | CARDINAL CAPITAL MANAGEMENT LLC | 1,088,265 6.8% | 168,271 (+18.29%) | View |
2021-02-16 09:34 am Sale | 13G | LIGAND PHARMACEUTICALS INC LGND | STATE STREET CORP STT | 1,165,390 7.25% | -88,322 (-7.04%) | View |
2021-02-12 10:15 am Purchase | 13G | LIGAND PHARMACEUTICALS INC LGND | MACQUARIE GROUP LTD | 913,653 5.68% | 913,653 (New Position) | View |
2021-02-11 4:42 pm Sale | 13G | LIGAND PHARMACEUTICALS INC LGND | JANUS HENDERSON GROUP PLC JHG | 1,612,369 10% | -234,841 (-12.71%) | View |
2021-02-11 2:54 pm Purchase | 13G | LIGAND PHARMACEUTICALS INC LGND | WILLIAM BLAIR INVESTMENT MANAGEMENT LLC | 2,041,045 12.7% | 145,671 (+7.69%) | View |
2021-02-10 6:16 pm Sale | 13G | LIGAND PHARMACEUTICALS INC LGND | RENAISSANCE TECHNOLOGIES LLC | 0 0% | -1,021,189 (Position Closed) | View |
2021-02-10 11:14 am Sale | 13G | LIGAND PHARMACEUTICALS INC LGND | VANGUARD GROUP INC | 1,458,925 9.07% | -111,088 (-7.08%) | View |
2021-02-09 3:06 pm Purchase | 13G | LIGAND PHARMACEUTICALS INC LGND | WASATCH ADVISORS LP | 1,168,997 7.3% | 1,168,997 (New Position) | View |
2021-02-08 5:19 pm Sale | 13G | LIGAND PHARMACEUTICALS INC LGND | BANK OF AMERICA CORP BAC | 211,653 1.3% | -827,529 (-79.63%) | View |
2021-01-26 6:52 pm Sale | 13G | LIGAND PHARMACEUTICALS INC LGND | BlackRock Inc. BLK | 1,965,996 12.2% | -419,162 (-17.57%) | View |
2021-01-15 4:11 pm Unchanged | 13G | SEELOS THERAPEUTICS INC SEEL | LIGAND PHARMACEUTICALS INC LGND | 2,224,000 4.1% | 0 (Unchanged) | View |
2020-10-08 09:17 am Purchase | 13G | LIGAND PHARMACEUTICALS INC LGND | WILLIAM BLAIR INVESTMENT MANAGEMENT LLC | 1,895,374 11.8% | 478,524 (+33.77%) | View |
2020-08-28 5:19 pm Sale | 13D | VIKING THERAPEUTICS INC VKTX | LIGAND PHARMACEUTICALS INC LGND | 7,339,383 9.9% | -218,700 (-2.89%) | View |
2020-02-14 1:16 pm Purchase | 13G | LIGAND PHARMACEUTICALS INC LGND | BANK OF AMERICA CORP BAC | 1,039,182 5.8% | 1,039,182 (New Position) | View |
2020-02-14 10:03 am Purchase | 13G | LIGAND PHARMACEUTICALS INC LGND | CARDINAL CAPITAL MANAGEMENT LLC | 919,994 5.2% | 67,863 (+7.96%) | View |
2020-02-14 07:44 am Purchase | 13G | LIGAND PHARMACEUTICALS INC LGND | STATE STREET CORP STT | 1,253,712 7.14% | 1,253,712 (New Position) | View |